$BIV BIOENVISION INC Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in BIOENVISION INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in BIOENVISION INC. Insider overview, share value development, latest insider transactions and email notifications about new events in BIOENVISION INC for free.
IRS Number: 113375915
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: BIV
Company Address: 345 PARK AVENUE 41ST FLOOR NEW YORK 10154
Former name: ASCOT GROUP INC, date of change: 1996-12-05
Prev close: $83.55
Average Daily Volume: 956,461
Days Low: $83.64
Year Low: $82.17
Year High: $88.58
BIOENVISION INC Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 12 2007 | BIV | BIOENVISION INC | Sterling Robert | VP-Product Developm ... | Sell | U | 5.60 | 15,225 | 85,260 | 0 | 15.2 K to 0 (-100.00 %) |
| Jul 12 2007 | BIV | BIOENVISION INC | WOOD CHRISTOPHER B | CEO and Chairman | Sell | U | 5.60 | 1,654,031 | 9,262,574 | 0 | 1.7 M to 0 (-100.00 %) |
| Jul 12 2007 | BIV | BIOENVISION INC | Nelson Thomas Scott | Director | Sell | U | 5.60 | 79,955 | 447,748 | 0 | 80 K to 0 (-100.00 %) |
| Jul 12 2007 | BIV | BIOENVISION INC | PERSEUS SOROS BIOPHARMACEUTICA ... | 10% Owner | Option Exercise | J | 0.00 | 2,250,000 | 0 | 0 | |
| Jul 12 2007 | BIV | BIOENVISION INC | PERSEUS SOROS BIOPHARMACEUTICA ... | 10% Owner | Sell | J | 5.60 | 3,375,044 | 18,900,246 | 0 | 3.4 M to 0 (-100.00 %) |
| Jul 12 2007 | BIV | BIOENVISION INC | LUCI DAVID P | EVP & General Couns ... | Sell | U | 5.60 | 310,154 | 1,736,862 | 0 | 310.2 K to 0 (-100.00 %) |
| Jul 11 2007 | BIV | BIOENVISION INC | GENZYME CORP | 10% Owner | Option Exercise | P | 0.00 | 2,250,000 | 0 | 2,250,000 | |
| Jul 11 2007 | BIV | BIOENVISION INC | GENZYME CORP | 10% Owner | Buy | P | 5.60 | 8,706,644 | 48,757,206 | 8,706,644 | 0 to 8.7 M |
| Jun 07 2007 | BIV | BIOENVISION INC | SCO CAPITAL PARTNERS LLC | 10% Owner | Option Exercise | X | 1.50 | 688,333 | 1,032,500 | 0 | |
| Jun 07 2007 | BIV | BIOENVISION INC | SCO CAPITAL PARTNERS LLC | 10% Owner | Buy | X | 1.50 | 688,333 | 1,032,500 | 6,807,297 | 6.1 M to 6.8 M (+11.25 %) |
| May 04 2007 | BIV | BIOENVISION INC | PERSEUS SOROS BIOPHARMACEUTICA ... | 10% Owner | Option Exercise | X | 6,000,000.00 | 1 | 6,000,000 | 0 | |
| May 04 2007 | BIV | BIOENVISION INC | PERSEUS SOROS BIOPHARMACEUTICA ... | 10% Owner | Buy | X | 2.00 | 3,000,000 | 6,000,000 | 3,375,044 | 375 K to 3.4 M (+799.91 %) |
| Jan 16 2007 | BIV | BIOENVISION INC | Nelson Thomas Scott | Director | Option Exercise | A | 4.67 | 25,000 | 116,750 | 40,000 | |
| Jan 16 2007 | BIV | BIOENVISION INC | WOOD CHRISTOPHER B | Chairman and CEO | Option Exercise | A | 4.67 | 157,500 | 735,525 | 2,552,500 | |
| Jan 16 2007 | BIV | BIOENVISION INC | Griffith Hugh | COO | Option Exercise | A | 4.67 | 140,000 | 653,800 | 90,000 |